Positive/margins following surgical resection of breast carcinoma: Analysis of pathologic correlates

Alexander R. Miller, Guillermo Brandao, Thomas J. Prihoda, Cheryl Hill, Anatolio B. Cruz, I. Tien Yeh

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Background and Objectives: Histologic margin positivity represents a significant source of adverse clinical outcome affecting breast conservation therapy for in situ or invasive malignancy. Elucidation of factors associated with positive margin status might clarify and improve local therapy strategies. In order to define our experience with margin positivity and to identify relevant pathologic criteria, we retrospectively analyzed the cases of 143 patients who underwent resections for carcinoma with intent of breast conservation between 1995 and 1999. Methods: Histologic features and indices of biologic aggressiveness were compared among tumors resected with positive versus negative margins in order to determine whether such markers could be used to anticipate outcome. Results: Twenty-eight pathologic specimens were identified to possess histologically positive margins. Twenty-six patients underwent additional operative procedures. Of the 26 re-excision specimens, 17 (65%) contained residual malignancy. Statistical analysis demonstrated that margin positivity correlated with in situ histology and with Her 2/neu positivity. Conclusions: These data suggest certain pathologic factors that may portend difficulty in achieving negative resection margins in patients in whom breast conservation therapy is considered.

Original languageEnglish (US)
Pages (from-to)134-140
Number of pages7
JournalJournal of Surgical Oncology
Volume86
Issue number3
DOIs
StatePublished - Jun 1 2004

Fingerprint

Segmental Mastectomy
Breast Neoplasms
Neoplasms
Operative Surgical Procedures
Histology
Breast
Carcinoma
Margins of Excision
Therapeutics

Keywords

  • Breast conservation
  • DCIS
  • Her 2/neu

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Miller, A. R., Brandao, G., Prihoda, T. J., Hill, C., Cruz, A. B., & Yeh, I. T. (2004). Positive/margins following surgical resection of breast carcinoma: Analysis of pathologic correlates. Journal of Surgical Oncology, 86(3), 134-140. https://doi.org/10.1002/jso.20059

Positive/margins following surgical resection of breast carcinoma : Analysis of pathologic correlates. / Miller, Alexander R.; Brandao, Guillermo; Prihoda, Thomas J.; Hill, Cheryl; Cruz, Anatolio B.; Yeh, I. Tien.

In: Journal of Surgical Oncology, Vol. 86, No. 3, 01.06.2004, p. 134-140.

Research output: Contribution to journalArticle

Miller, Alexander R. ; Brandao, Guillermo ; Prihoda, Thomas J. ; Hill, Cheryl ; Cruz, Anatolio B. ; Yeh, I. Tien. / Positive/margins following surgical resection of breast carcinoma : Analysis of pathologic correlates. In: Journal of Surgical Oncology. 2004 ; Vol. 86, No. 3. pp. 134-140.
@article{64a8c21ae011441f92c0d9c5df4bfa09,
title = "Positive/margins following surgical resection of breast carcinoma: Analysis of pathologic correlates",
abstract = "Background and Objectives: Histologic margin positivity represents a significant source of adverse clinical outcome affecting breast conservation therapy for in situ or invasive malignancy. Elucidation of factors associated with positive margin status might clarify and improve local therapy strategies. In order to define our experience with margin positivity and to identify relevant pathologic criteria, we retrospectively analyzed the cases of 143 patients who underwent resections for carcinoma with intent of breast conservation between 1995 and 1999. Methods: Histologic features and indices of biologic aggressiveness were compared among tumors resected with positive versus negative margins in order to determine whether such markers could be used to anticipate outcome. Results: Twenty-eight pathologic specimens were identified to possess histologically positive margins. Twenty-six patients underwent additional operative procedures. Of the 26 re-excision specimens, 17 (65{\%}) contained residual malignancy. Statistical analysis demonstrated that margin positivity correlated with in situ histology and with Her 2/neu positivity. Conclusions: These data suggest certain pathologic factors that may portend difficulty in achieving negative resection margins in patients in whom breast conservation therapy is considered.",
keywords = "Breast conservation, DCIS, Her 2/neu",
author = "Miller, {Alexander R.} and Guillermo Brandao and Prihoda, {Thomas J.} and Cheryl Hill and Cruz, {Anatolio B.} and Yeh, {I. Tien}",
year = "2004",
month = "6",
day = "1",
doi = "10.1002/jso.20059",
language = "English (US)",
volume = "86",
pages = "134--140",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Positive/margins following surgical resection of breast carcinoma

T2 - Analysis of pathologic correlates

AU - Miller, Alexander R.

AU - Brandao, Guillermo

AU - Prihoda, Thomas J.

AU - Hill, Cheryl

AU - Cruz, Anatolio B.

AU - Yeh, I. Tien

PY - 2004/6/1

Y1 - 2004/6/1

N2 - Background and Objectives: Histologic margin positivity represents a significant source of adverse clinical outcome affecting breast conservation therapy for in situ or invasive malignancy. Elucidation of factors associated with positive margin status might clarify and improve local therapy strategies. In order to define our experience with margin positivity and to identify relevant pathologic criteria, we retrospectively analyzed the cases of 143 patients who underwent resections for carcinoma with intent of breast conservation between 1995 and 1999. Methods: Histologic features and indices of biologic aggressiveness were compared among tumors resected with positive versus negative margins in order to determine whether such markers could be used to anticipate outcome. Results: Twenty-eight pathologic specimens were identified to possess histologically positive margins. Twenty-six patients underwent additional operative procedures. Of the 26 re-excision specimens, 17 (65%) contained residual malignancy. Statistical analysis demonstrated that margin positivity correlated with in situ histology and with Her 2/neu positivity. Conclusions: These data suggest certain pathologic factors that may portend difficulty in achieving negative resection margins in patients in whom breast conservation therapy is considered.

AB - Background and Objectives: Histologic margin positivity represents a significant source of adverse clinical outcome affecting breast conservation therapy for in situ or invasive malignancy. Elucidation of factors associated with positive margin status might clarify and improve local therapy strategies. In order to define our experience with margin positivity and to identify relevant pathologic criteria, we retrospectively analyzed the cases of 143 patients who underwent resections for carcinoma with intent of breast conservation between 1995 and 1999. Methods: Histologic features and indices of biologic aggressiveness were compared among tumors resected with positive versus negative margins in order to determine whether such markers could be used to anticipate outcome. Results: Twenty-eight pathologic specimens were identified to possess histologically positive margins. Twenty-six patients underwent additional operative procedures. Of the 26 re-excision specimens, 17 (65%) contained residual malignancy. Statistical analysis demonstrated that margin positivity correlated with in situ histology and with Her 2/neu positivity. Conclusions: These data suggest certain pathologic factors that may portend difficulty in achieving negative resection margins in patients in whom breast conservation therapy is considered.

KW - Breast conservation

KW - DCIS

KW - Her 2/neu

UR - http://www.scopus.com/inward/record.url?scp=2642511578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2642511578&partnerID=8YFLogxK

U2 - 10.1002/jso.20059

DO - 10.1002/jso.20059

M3 - Article

C2 - 15170651

AN - SCOPUS:2642511578

VL - 86

SP - 134

EP - 140

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -